Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 19 citing articles:

PROTACs: Novel tools for improving immunotherapy in cancer
Shizhe Li, Ting Chen, Jinxin Liu, et al.
Cancer Letters (2023) Vol. 560, pp. 216128-216128
Closed Access | Times Cited: 25
Therapy-induced senescence as a component of tumor biology: Evidence from clinical cancer
Tareq Saleh, Sarah Bloukh, Mira Hasan, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188994-188994
Closed Access | Times Cited: 18
Autophagy and senescence facilitate the development of antiestrogen resistance in ER positive breast cancer
Michael K. McGrath, Ali Abolhassani, Luke Guy, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6
The Cytoprotective and Cytotoxic Functions of Autophagy in Response to mTOR Inhibitors
Ahmed M. Elshazly, Aya A. Elzahed, David A. Gewirtz
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 6, pp. 231-231
Open Access | Times Cited: 4
Unveiling the complexity of cellular senescence in cancers: From mechanism to therapeutic opportunities
Qiuming Pan, Zhu Ye, Zhi Ting Ye, et al.
BMEMat (2025)
Open Access
CDK4/6 inhibitors upregulate cIAP1/2, and Smac mimetic LCL161 enhances their antitumor effects in cholangiocarcinoma cells
Pimchanok Menapree, Nattaya Duangthim, Apiwit Sae-Fung, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Pharmacological Modulation of Cellular Senescence: Implications for Breast Cancer Progression and Therapeutic Strategies
Jialing Xie, Xinxin Shu, Zilan-Xie, et al.
European Journal of Pharmacology (2025), pp. 177475-177475
Closed Access
Advances in research on autophagy mechanisms in resistance to endometrial cancer treatment
Jingjing Ji, Xi Cheng, Rong Du, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
SCF FBXW5 -mediated degradation of AQP3 suppresses autophagic cell death through the PDPK1-AKT-MTOR axis in hepatocellular carcinoma cells
Yupei Liang, Ping Chen, Shiwen Wang, et al.
Autophagy (2024) Vol. 20, Iss. 9, pp. 1984-1999
Closed Access | Times Cited: 3
Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors?
Ahmed M. Elshazly, Jingwen Xu, Nebras Y. Melhem, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2989-2989
Open Access | Times Cited: 3
Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET Inhibitors
Ahmed M. Elshazly, David A. Gewirtz
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12669-12669
Open Access | Times Cited: 8
BRD4 Inhibition as a Strategy to Prolong the Response to Standard of Care in Estrogen Receptor-Positive Breast Cancer
Ahmed M. Elshazly, Melanie M. Sinanian, Victoria Neely, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4066-4066
Open Access | Times Cited: 7
Evidence for cytoprotective autophagy in response to HER2-targeted monoclonal antibodies
Ahmed M. Elshazly, Aya A. Elzahed, David A. Gewirtz
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 1, pp. 100007-100007
Open Access | Times Cited: 2
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research
Ahmed M. Elshazly, Uruk Shahin, Sofian Al Shboul, et al.
Molecular Pharmacology (2024) Vol. 105, Iss. 5, pp. 313-327
Open Access | Times Cited: 2
Therapy-induced senescence is finally escapable, what is next?
Tareq Saleh
Cell Cycle (2024) Vol. 23, Iss. 6, pp. 713-721
Closed Access | Times Cited: 2
Unlocking the Potential of Camel Milk-Derived Exosomes as Novel Delivery Systems: Enhanced Bioavailability of ARV-825 PROTAC for Cancer Therapy
Aakash Nathani, Mounika Aare, Li Sun, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1070-1070
Open Access | Times Cited: 2
The Cytoprotective Role of Autophagy in Response to BRAF-Targeted Therapies
Ahmed M. Elshazly, David A. Gewirtz
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14774-14774
Open Access | Times Cited: 5
Estradiol induces bone osteolysis in triple–negative breast cancer via its membrane–associated receptor ERα36
David J. Cohen, Cydney D. Dennis, Jingyao Deng, et al.
JBMR Plus (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 1
Prevalence and genetic spectrum associated with hereditary colorectal cancer syndromes, the need to improve cancer risk awareness, and family cascade testing in Vietnam
Huu Thinh Nguyen, Y‐Thanh Lu, Duc Huy Tran, et al.
Familial Cancer (2023) Vol. 22, Iss. 4, pp. 449-458
Closed Access | Times Cited: 3
Page 1

Scroll to top